PT1791571E - Péptidos radiofluorados - Google Patents

Péptidos radiofluorados Download PDF

Info

Publication number
PT1791571E
PT1791571E PT05790076T PT05790076T PT1791571E PT 1791571 E PT1791571 E PT 1791571E PT 05790076 T PT05790076 T PT 05790076T PT 05790076 T PT05790076 T PT 05790076T PT 1791571 E PT1791571 E PT 1791571E
Authority
PT
Portugal
Prior art keywords
radiofluorinated
peptides
processes
radiopharmaceuticals
iiia
Prior art date
Application number
PT05790076T
Other languages
English (en)
Inventor
Magne Solbakken
Bente Arbo
Alan Cuthbertson
Alexander Gibson
Original Assignee
Ge Healthcare Ltd
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd, Ge Healthcare As filed Critical Ge Healthcare Ltd
Publication of PT1791571E publication Critical patent/PT1791571E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT05790076T 2004-09-14 2005-09-14 Péptidos radiofluorados PT1791571E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds

Publications (1)

Publication Number Publication Date
PT1791571E true PT1791571E (pt) 2008-11-19

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05790076T PT1791571E (pt) 2004-09-14 2005-09-14 Péptidos radiofluorados

Country Status (24)

Country Link
US (2) US7875701B2 (pt)
EP (1) EP1791571B1 (pt)
JP (1) JP4949251B2 (pt)
KR (1) KR101243016B1 (pt)
CN (1) CN101151054B (pt)
AT (1) ATE404225T1 (pt)
AU (1) AU2005283904B8 (pt)
BR (1) BRPI0515175A (pt)
CA (1) CA2578470C (pt)
DE (1) DE602005008996D1 (pt)
DK (1) DK1791571T3 (pt)
ES (1) ES2312018T3 (pt)
GB (1) GB0420344D0 (pt)
HK (1) HK1118713A1 (pt)
IL (1) IL181529A (pt)
MX (1) MX2007003019A (pt)
NO (1) NO20071880L (pt)
NZ (1) NZ553384A (pt)
PL (1) PL1791571T3 (pt)
PT (1) PT1791571E (pt)
RU (1) RU2396272C9 (pt)
SI (1) SI1791571T1 (pt)
WO (1) WO2006030291A2 (pt)
ZA (1) ZA200702700B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
AU2007294685B2 (en) * 2006-09-15 2012-06-07 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
US8247534B2 (en) 2006-12-13 2012-08-21 Ge Healthcare As Synthesis of radiofluorinated peptide using microwave activation technology
WO2008075966A2 (en) * 2006-12-18 2008-06-26 Ge Healthcare As Synthesis of a radiofluorinated peptide using photolabile protecting groups
EP2114464A2 (en) 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorination methods
MX2009009291A (es) * 2007-03-01 2009-12-14 Bayer Schering Pharma Ag Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
CN101854957B (zh) 2007-09-10 2013-05-22 通用电气健康护理有限公司 放射性氟化方法
JP5399422B2 (ja) * 2008-02-28 2014-01-29 ジーイー・ヘルスケア・リミテッド 市販の安価な化学薬品からのｐｅｇ−６成分の合成
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
US20120229804A1 (en) 2009-12-21 2012-09-13 Medi-Physics, Inc. Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f- ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
JP6231882B2 (ja) 2010-12-01 2017-11-15 ジーイー・ヘルスケア・リミテッド 放射性コンジュゲーション方法
CN107753962A (zh) * 2010-12-09 2018-03-06 通用电气健康护理有限公司 放射性示踪剂组合物
CA2822583A1 (en) * 2010-12-21 2012-06-28 Ge Healthcare Limited Use of aniline in the radiostabilization of oxime ligation reactions
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
EP3226884B1 (en) 2014-12-04 2021-02-17 GE Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
WO2006030291A2 (en) 2006-03-23
CA2578470A1 (en) 2006-03-23
ZA200702700B (en) 2008-09-25
GB0420344D0 (en) 2004-10-13
DE602005008996D1 (de) 2008-09-25
ES2312018T3 (es) 2009-02-16
IL181529A0 (en) 2007-07-04
US8563600B2 (en) 2013-10-22
HK1118713A1 (en) 2009-02-20
KR20070053750A (ko) 2007-05-25
EP1791571A2 (en) 2007-06-06
CN101151054B (zh) 2014-09-24
US7875701B2 (en) 2011-01-25
DK1791571T3 (da) 2008-12-08
US20110117016A1 (en) 2011-05-19
NO20071880L (no) 2007-06-13
JP4949251B2 (ja) 2012-06-06
KR101243016B1 (ko) 2013-03-12
JP2008516894A (ja) 2008-05-22
CA2578470C (en) 2015-09-01
AU2005283904B8 (en) 2012-02-23
SI1791571T1 (sl) 2009-02-28
RU2007108762A (ru) 2008-10-27
IL181529A (en) 2015-04-30
RU2396272C2 (ru) 2010-08-10
MX2007003019A (es) 2007-08-07
CN101151054A (zh) 2008-03-26
EP1791571B1 (en) 2008-08-13
NZ553384A (en) 2011-02-25
PL1791571T3 (pl) 2009-01-30
WO2006030291A3 (en) 2007-06-14
AU2005283904A1 (en) 2006-03-23
BRPI0515175A (pt) 2008-07-08
RU2396272C9 (ru) 2010-12-10
US20080095701A1 (en) 2008-04-24
ATE404225T1 (de) 2008-08-15
AU2005283904B2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
PL1791571T3 (pl) Radiofluorowane peptydy
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MXPA05009682A (es) Metodos de radiofluorinacion de vectores biologicamente activos.
TN2010000213A1 (en) Wise binding antibodies and epitopes
IL220412A0 (en) Antibodies which bind to gm-csf, polynucleotides encoding the same, pharmaceutical compositions containing the same and uses thereof
TW200505875A (en) Novel compounds
NZ612161A (en) Radiolabled her2 binding peptides
NO20092611L (no) Krystallinsk faststoff Rasagilin base
IL191655A0 (en) Novel compounds, their preparation and use
TW200621313A (en) Pharmaceutical compositions
IL186828A0 (en) Vaccine composition
TW200800967A (en) Benzimidazole thiophene compounds
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
TW200736227A (en) New compounds III
TW200745122A (en) New compounds I
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
WO2009035959A3 (en) Radiofluorination methods
TW200745133A (en) New compounds II
GB0615105D0 (en) Novel compounds
WO2008083191A3 (en) Radiofluorination methods
TW200633717A (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
EA200870565A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение